CVS to sell its troubled long-term care pharmacy
GenieRx→Omnicare
May 14, 2026
Shyld AI has completed the acquisition of Shyld AI, a medical devices business in California, for $13.4 million. Shyld AI develops an AI-powered UV disinfection platform that autonomously sanitizes hospital rooms to help reduce hospital-acquired infection risk and improve cleaning consistency. The system is designed to lower reliance on labor-intensive environmental services workflows in healthcare facilities across California. This other acquisition supports Shyld AI expansion with a healthcare M&A strategy focused on scaling autonomous medical device deployment, with deal size reported at $13.4 million and an announced status.
GenieRx→Omnicare
May 14, 2026
Amarox→CEL-SCI
May 14, 2026
Create Medicines
May 14, 2026
Zydus Worldwide DMCC→Assertio Holdings
May 14, 2026
Biogen→Apellis Pharmaceuticals
May 14, 2026